pharma · Cocaine-Related Disorders · Cocaine Dependence · DRUG
BRIGHT MINDS BIOSCIENCES
BRIGHT MINDS BIOSCIENCES INC.
BRIGHT MINDS BIOSCIENCES patent portfolio — 57 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 19 Vestry St, New York, NY 10013, US
- Employees
- 12
- Programs
- 1063
- Drugs
- 444
- Patents
- 57
BRIGHT MINDS BIOSCIENCES patents
57 pharmaceutical patents indexed for BRIGHT MINDS BIOSCIENCES. 4 expire within 24 months.
BRIGHT MINDS BIOSCIENCES has 57 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 4 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12383631
Immune antigen specific IL-18 immunocytokines and uses thereof
granted -
US 12350120
Gum-protecting and teeth-whitening strip and preparation method thereof
granted -
US 12220447
Proteolytic enzyme composition
granted -
US 12215133
GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use
granted -
US 12173062
Modified TNF-α antibodies and uses thereof
granted -
US 12115136
Fortified CBD oil for treatment of PTSD
granted -
US 12097230
Method and composition for treating post operative conditions
granted -
US 11925686
Materials for phototherapies of ophthalmic diseases
granted -
US 11865288
Devices for applying a topical treatment
granted -
US 11723881
Fortified CBD oil for treatment of PTSD
granted -
US 11647776
Extract, consumable product and method for enriching bioactive metabolite in an extract
granted -
US 11642323
Method for modulating metabolism
granted -
US 11633488
Modified IL-2 polypeptides and uses thereof
granted -
US 11382880
Method for improving digestive health
granted -
US 11344707
Devices for applying a topical treatment
granted -
US 11331383
Attenuated african swine fever virus vaccine
granted -
US 11253445
Oxidative hair color remover in tablet or pellet form
granted -
US 11202825
Attenuated infectious bronchitis virus
granted -
US 11197833
Fortified CBD oil for treatment of PTSD
granted -
US 11191761
SOMCL-9112 solid dispersion and preparation method thereof and SOMCL-9112 solid preparation containing SOMCL-9112 solid dispersion
granted -
US 11191843
Multi-arm targeting anti-cancer conjugate
granted -
US 11179467
Exenatide modifier and use thereof
granted -
US 11173136
Method for modulating metabolism
granted -
US 11053286
Stabilised FMDV capsids
granted -
US 11045466
Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
granted -
US 10946308
Enzymatic method for extraction and purification of phytocannabinoids
granted -
US 10869863
Multi-arm polymeric targeting anti-cancer conjugate
granted -
US 10759905
Biodegradable amphiphilic polymer, polymeric vesicles prepared therefrom, and application of biodegradable amphiphilic polymer in preparation of medicines for targeted therapy of lung cancer
granted -
US 10738275
Paenibacillus sp. strain, cultivation method and use of the same
granted -
US 10689413
Composition enriched in single isomer of NUC-1031 and preparation method and use thereof
granted -
US 10548890
Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
granted -
US 10507237
Attenuated African swine fever virus vaccine
granted -
US 10307418
Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
granted -
US 10292940
Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof
granted -
US 10294277
Stabilised FMDV capsids
granted -
US 10202578
Chicken cells for improved virus production
granted -
US 10130701
Coronavirus
granted -
US 10113145
Paenibacillus sp. strain, cultivation method and use of the same
granted -
US 10098925
Protein SLURP-1 for use in the treatment of ocular diseases
granted -
US 10072122
Carbonate polymer containing a functional group of disulfide five-membered ring in the side chain and application thereof
granted -
US 10028949
Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
granted -
US 9969777
Mutant spike protein extending the tissue tropism of infectious bronchitis virus (IBV)
granted -
US 9844568
Porous carbon particles for use in the treatment or prevention of liver disease
granted -
US 9796728
Cyclic carbonate monomer containing double-sulfur five-membered ring functional group, and preparation method thereof
granted -
US 9724345
Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
granted -
US 9457075
Modified foot and mouth disease virus (FMDV) VP1 capsid protein
granted -
US 9243230
Construct for producing empty virus capsids
granted -
US 9145548
Foot and mouth disease virus with increased stability and its use as vaccine
granted
Frequently asked questions
How many patents does BRIGHT MINDS BIOSCIENCES have?
57 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do BRIGHT MINDS BIOSCIENCES patents expire?
4 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.